A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 4, 1999, Pages 581-586

  Martinez, Joseph E ^a   Romero Steiner, Sandra ^a   Pilishvili, Tamara ^a   Barnard, Suzanne ^a   Schinsky, Joseph ^a   Goldblatt, David ^b   Carlone, George M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Institute for Child Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; NORMAL HUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0032798037     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.4.581-586.1999     Document Type: Article

References (28)

1. Anttila, M., J. Eskola, H. Åhman, and H. Käyhty. 1998. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharidcs in infants primed with pneumococcal conjugates and boosted with polysaceharide or conjugate vaccines. J. Infect. Dis. 177:1614-1621.
2. Brinkley, M. 1992. A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconjugate Chem. 3:2.
3. Coughlin, R. T., A. C. White, C. A. Anderson, G. M. Carlone, D. L. Klein, and J. Treanor. 1998. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 16:1761-1767.
4. De Velasco, A. E., A. F. M. Verheul, A. M. P. Van Steijn, H. A. T. Dekker, R. G. Feldman, I. M. Fernandez, J. P. Karmerling, J. F. G. Vliegenthart., J. Verhoef, and H. Snippe. 1994. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Infect. Immun. 62:799-808.
5. Esposito, A. L., C. A. Clark, and W. J. Poirier. 1990. An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro. APMIS 98:111-121.
6. Fedson, D. S., and D. M. Musher. 1994. Pneumococcal vaccine, p. 517-564. In S. A. Plotkin and E. A. Mortimer, Jr. (ed.). Vaccines, 2nd ed. The W. B. Saunders Co., Philadelphia, Pa.
7. Fothergill, L., and J. Wright. 1993. Influenzal meningitis: relation of age incidence to the bactericidal power of blood against the causal organism. J. Immunol. 24:273-284.
8. Guckian, J. C., G. D. Christensen, and D. P. Fine. 1980. Role of opsonins in recovery from experimental pneumococcal pneumonia. J. Infect. Dis. 142: 175-190.
9. Hed, J., G. Hallden, S. G. O. Johansson, and P. Larson. 1987. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J. Immunol. Methods 101:119-125.
10. Kaniuk, A., J. E. Lortan, and M. A. Monteil. 1992. Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization. Scand. J. Immunol. 36(Suppl. 11):96-98.
11. Käyhty, H., H. Peltola, V. Kankako, and P. H. Mäkelä. 1983. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus injluenzae type b. J. Infect. Dis. 147:1100.
12. Jansen, W., M. Breukels, L. Sanders, D. Van Kessel, A. J. Van Houte, P. Horikx, H. Van Velzen, H. Snipe, A. Verheul, and G. Rijkers. 1998. The allotype of FcγRIIa receptor determines the extent of phagocytosis of Streptococcus pneumoniae by human polymorphonuclear leukocytes: implications for the evaluation of pneumococcal vaccines, abstr. G-63, p. 302. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Jansen, W. T. M., J. Gootjes, M. Zelle, D. V. Madore, J. Verhoef, H. Snippe, and A. F. M. Verheul. 1998. Use of highly encapsulated Streptococcus pneumoniae strains in a flow cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin. Diagn. Lab. Immunol. 5:703-710.
14. Lortan, J. E., A. S. Kaniuk, and M. A. Monteil. 1993. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin. Exp. Immunol. 91:54-57.
15. Nahm, M. H., G. R. Siber, and J. V. Olander. 1996. A modified Farr assay is more specific than the ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J. Infect. Dis. 173:113-118.
16. Neufeld, F. 1902. Uber die agglutina der Pneumokokken und uber die Theorien der Agglutination. Z. Hyg. Infecktionskr. 40:54-72.
17. Obaro, S. K., D. C. Henderson, and M. A. Monteil. 1996. Defective antibody-mediated opsonisation of S. pneumoniae in high risk patients detected by flow cytometry. Immunol. Lett. 49:83-89.
18. Plikaytis, B., G. Carlone, D. Goldblatt, and Participating Laboratories. 1998. Analytical methods applied to a multi-center pneumococcal ELISA study, abstr. P52, p. 71. In Program and abstracts of the First International Symposium on Pneumococci and Pneumococcal Diseases.
19. Quataert, S. A., C. S. Kirch, L. J. Quackenbush Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard refeence serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
20. Romero-Steiner, S., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
21. Romero-Steiner, S., L. B. Pais, L. Groover, D. M. Musher, A. Fiore, M. Cetron, B. D. Plikaytis, and G. M. Carlone. 1997. Evaluation of functional antibody responses in elderly and middle aged vaccinees to the 23-valent pneumococcal polysaccharide vaccine, abstr. E-64, p. 251. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
22. Romero-Steiner, S., M. Carvalho, S. Barnard, J. O. Kim, J. Weiser, and G. M. Carlone. 1998. Decreased opsonophagocytosis activity in the pneumococcal opaque phenotype is associated with higher capsule polysaccharide content, abstr. G-110, p. 314. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Schiffman, G., R. M. Douglas, M. J. Bonner, M. Robins, and R. Austrian. 1980. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J. Immunol. Methods 33:133-144.
24. Shatz, D., M. F. Schinsky, L. B. Pais, S. Romero-Steiner, O. C. Kirton, and G. M. Carlone. 1998. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 vs 7 vs 14 days postsplenectomy. J. Trauma 44:760-766.
25. Sveum, R. J., T. M. Chused, M. M. Frank, and E. J. Brown. 1986. A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. J. Immunol. Methods 90:257-264.
26. Vióarsson, G., I. Jönsdóttir, S. Jonsson, and H. Valdimarsson. 1994. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. 3. Infect. Dis. 170:592-599.
27. Wenger, J. D., S. R. Steiner, L. B. Pais, J. C. Butler, B. Perkins, G. M. Carlone, and C. V. Broome. 1996. Laboratory correlates for protective efficacy of pneumococcal vaccines: how can they be identified and validated?, abstr. G37, p. 150. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
28. Wilkelstein, J. A., M. R. Smith, and H. S. Shin. 1975. The role of C3 as an opsonin in the early stages of infection. Proc. Soc. Exp. Biol. Med. 149:397-401.